Cross-linking of B7-H1 on EBV-transformed B cells induces apoptosis through reactive oxygen species production, JNK signaling activation, and fasL expression

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6158-6169

  Yeong, Seok Kim ^a   Ga, Bin Park ^a   Lee, Hyun Kyung ^b   Song, Hyunkeun ^a   Choi, In Hak ^a   Wang, Jae Lee ^c   Dae, Young Hur ^a  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; B7 ANTIGEN; B7 H1 ANTIBODY; B7 H1 PROTEIN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; FAS ANTIBODY; FAS LIGAND; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; N BENZYLOXYCARBONYL VALYLALANYLASPARTIC ACID FLUOROMETHYLKETONE; PROTEIN C JUN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; B7 RELATED PROTEIN 1; B7-RELATED PROTEIN-1; CROSS LINKING REAGENT; FASLG PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; VIRUS CELL TRANSFORMATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MARMOSET; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; APOPTOSIS; B-LYMPHOCYTE SUBSETS; CALLITHRIX; CELL LINE, TRANSFORMED; CROSS-LINKING REAGENTS; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HERPESVIRUS 4, HUMAN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 58749088581     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6158     Document Type: Article

References (42)

1. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
2. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
3. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800. (Pubitemid 34887242)
4. Petroff, M. G., L. Chen, T. A. Phillips, and J. S. Hunt. 2002. B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta 23 (Suppl. A): S95-S101.
5. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170: 1257-1266.
6. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545. (Pubitemid 35291652)
7. Mazanet, M. M., and C. C. Hughes. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169: 3581-3588.
8. Ishida, Y., Y. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11: 3887-3895.
9. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, K. Okumura, et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163. (Pubitemid 37238692)
10. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700.
11. Dong, H., S. E. Strome, E. L. Matteson, K. G. Moder, D. B. Flies, G. Zhu, H. Tamura, C. L. Driscoll, and L. Chen. 2003. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 111: 363-370. (Pubitemid 36182213)
12. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
13. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
14. Strome, S. E., H. Dong, H. Tamura, S. G. Voss, D. B. Flies, K. Tamada, D. Salomao, J. Cheville, F. Hirano, W. Lin, et al. 2003. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res. 63: 6501-6505.
15. Konishi, J., K. Yamazaki, M. Azuma, I. Kinoshita, H. Dosaka-Akita, and M. Nishimura. 2004. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin. Cancer Res. 10: 5094-5100. (Pubitemid 39106851)
16. Wu, C., Y. Zhu, J. Jiang, J. Zhao, X. G. Zhang, and N. Xu. 2006. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 108: 19-24.
17. Salih, H. R., S. Wintterle, M. Krusch, A. Kroner, Y. H. Huang, L. Chen, and H. Wiendl. 2006. The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. Exp. Hematol. 34: 888-894.
18. Dong, H., and L. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81: 281-287. (Pubitemid 36718324)
19. Hirano, F., K. Kaneko, H. Tamura, H. Dong, S. Wang, M. Ichikawa, C. Rietz, D. B. Flies, J. S. Lau, G. Zhu, et al. 2005. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 65: 1089-1096. (Pubitemid 40216472)
20. Thompson, R. H., W. S. Webster, J. C. Cheville, C. M. Lohse, H. Dong, B. C. Leibovich, S. M. Kuntz, S. Sengupta, E. D. Kwon, and M. L. Blute. 2005. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. Urology 66: 10-14.
21. Blank, C., J. Kuball, S. Voelkl, H. Wiendl, B. Becker, B. Walter, O. Majdic, T. F. Gajewski, M. Theobald, R. Andreesen, and A. Mackensen. 2006. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int. J. Cancer 119: 317-327. (Pubitemid 43911896)
22. Jeannin, P., Y. Delneste, S. Lecoanet-Henchoz, J. F. Gauchat, J. Ellis, and J. Y. Bonnefoy. 1997. CD86 (B7-2) on human B cells: a functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J. Biol. Chem. 272: 15613-111619 (Pubitemid 27265529)
23. Van Keulen, V. P., B. Ciric, S. Radhakrishnan, K. L. Heckman, Y. Mitsunaga, K. Iijima, H. Kita, M. Rodriguez, and L. R. Pease. 2006. Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12. Clin. Exp. Immunol. 143: 314-321.
24. Kutok, J. L., and F. Wang. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1: 375-404.
25. Ambinder, R. F. 2007. Epstein-barr virus and Hodgkin lymphoma. Hematology Am. Soc. Hematol. Educ. Program 2007: 204-209.
26. + T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
27. Yamamoto, R., M. Nishikori, T. Kitawaki, T. Sakai, M. Hishizawa, M. Tashima, T. Kondo, K. Ohmori, M. Kurata, T. Hayashi, and T. Uchiyama. 2008. PD-1-PD-1-ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111: 3220-3224.
28. Kim, Y. S., G. B. Park, Y. M. Choi, O. S. Kwon, H. K. Song, J. S. Kang, Y. I. Kim, W. J. Lee, and D. Y. Hur. 2006. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus-transformed B lymphocytes induces cell death in a reactive oxygen species-dependent manner. Hum. Immunol. 67: 795-807.
29. Jacobson, M. D. 1996. Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21: 83-86. (Pubitemid 26088517)
30. Camhi, S. L., P. Lee, and A. M. Choi. 1995. The oxidative stress response. New Horiz. 3: 170-182.
31. Tan, S., Y. Sagara, Y. Liu, P. Maher, and D. Schubert. 1998. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141: 1423-1432. (Pubitemid 28289917)
32. Hampton, M. B., B. Fadeel, and S. Orrenius. 1998. Redox regulation of the caspases during apoptosis. Ann. NY Acad. Sci. 854: 328-335.
33. Andreyev, A. Y., Y. E. Kushnareva, and A. A. Starkov. 2005. Mitochondrial metabolism of reactive oxygen species. Biochemistry 70: 200-214. (Pubitemid 40512329)
34. Hsu, W. H., Y. S. Hsieh, H. C. Kuo, C. Y. Teng, H. I. Huang, C. J. Wang, S. F. Yang, Y. S. Liou, and W. H. Kuo. 2007. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch. Toxicol. 81: 719-728.
35. Saelens, X., N. Festjens, L. Vande Walle, M. van Gurp, G. van Loo, and P. Vandenabeele. 2004. Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874. (Pubitemid 38638848)
36. Broker, L. E., F. A. Kruyt, and G. Giaccone. 2005. Cell death independent of caspases: a review. Clin. Cancer Res. 11: 3155-3162. (Pubitemid 40627860)
37. Cho, S. G., and E. J. Choi. 2002. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J. Biochem. Mol. Biol. 35: 24-27. (Pubitemid 35216579)
38. Zhuang, S., and R. G. Schnellmann. 2006. A death-promoting role for extracellular signal-regulated kinase. J. Pharmacol. Exp. Ther. 319: 991-997. (Pubitemid 44776445)
39. Cross, T. G., D. Scheel-Toellner, N. V. Henriquez, E. Deacon, M. Salmon, and J. M. Lord. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256: 34-41.
40. Nagata, Y., and K. Todokoro. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94: 853-863. (Pubitemid 29361815)
41. van den Berg, R., G. R. Haenen, H. van den Berg, and A. Bast. 2001. Transcription factor NF-κB as a potential biomarker for oxidative stress. Br. J. Nutr. 86 (Suppl. 1): S121-S127.
42. Stel, A. J., B. Ten Cate, S. Jacobs, J. W. Kok, D. C. Spierings, M. Dondorff, W. Helfrich, H. C. Kluin-Nelemans, L. F. de Leij, S. Withoff, and B. J. Kroesen. 2007. Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J. Immunol. 178: 2287-2295.